Coffee polyphenols exert hypocholesterolemic effects in zebrafish fed a high-cholesterol diet

Nutrition & Metabolism

Tadashi Hase¹  Takahiro Hasumura¹  Shinichi Meguro¹ 

[1] Biological Science Research, Kao Corporation, 2606 Akabane, Ichikai-machi, Haga-gun, Tochigi 321-3497, Japan

关键词: Zebrafish;    Vascular lipid accumulation;    Microsomal triglyceride transfer protein;    Hypercholesterolemia;    3-hydroxy-3- methylglutaryl-coenzyme A reductase;    Cytochrome P450 7A1;    Coffee polyphenols;    Cholesterol diet;    Chlorogenic acids;   

Others  :  803169
DOI  :  10.1186/1743-7075-10-61

 received in 2013-05-19, accepted in 2013-09-26,  发布年份 2013

【 摘 要 】

Background

Hypercholesterolemia is an important risk factor for the development of coronary artery disease. Some dietary polyphenols, such as coffee polyphenols (CPPs), reduce cholesterol levels. The mechanism of this cholesterol-lowering effect is not fully understood, although 5-CQA, a major component of CPPs, reportedly inhibits cholesterol biosynthesis. Here, we investigated the mechanism of the cholesterol-lowering effect of CPPs on the basis of cholesterol metabolism–related gene expression in the liver. We also examined the effects of CPPs on vascular lipid accumulation in zebrafish with high cholesterol diet–induced hypercholesterolemia.

Methods

Over 14 weeks, adult zebrafish were fed a control diet, a high-cholesterol diet, or the latter diet supplemented with CPPs. To measure the extent of vascular lipid accumulation, for 10 days larval zebrafish (which are optically transparent) were fed these same diets with the addition of a fluorescent cholesteryl ester.

Results

In adult zebrafish, addition of CPPs to a high-cholesterol diet significantly suppressed the increase in plasma and liver cholesterol levels seen when fish ingested the same diet lacking CPPs. Transcription levels of the liver genes hmgcra (encoding 3-hydroxy-3-methylglutaryl-coenzyme A reductase A, a rate-limiting enzyme in cholesterol biosynthesis) and mtp (encoding microsomal triglyceride transfer protein, a lipid transfer protein required for assembly and secretion of lipoproteins) were significantly lower in fish fed the CPP-containing diet than in fish fed the unsupplemented high-cholesterol diet. In contrast, the expression level of the liver gene cyp7a1a (encoding the cytochrome P450 polypeptide 1a of subfamily A of family 7, a rate-limiting enzyme for bile acid biosynthesis) increased significantly upon consumption of the CPP-containing diet. In larval fish, accumulation of fluorescently labeled cholesterol in the caudal artery was greatly reduced on the CPP-containing diet.

Conclusions

CPP ingestion suppressed cholesterol accumulation in the plasma, liver, and vascular system of zebrafish. Downregulation of cholesterol and lipoprotein synthesis and upregulation of bile acid synthesis in the liver may be the fundamental underlying mechanisms by which CPPs exert their hypocholesterolemic effects. CPP intake may help prevent and manage hypercholesterolemia in humans, and further investigations along these lines using a variety of CPP dose rates are warranted.

【 授权许可】

   
2013 Meguro et al.; licensee BioMed Central Ltd.

【 图 表 】

Figure 1.

Figure 2.

Figure 3.

Figure 4.

【 参考文献 】

• [1]van der Wulp MY, Verkade HJ, Groen AK: Regulation of cholesterol homeostasis. Mol Cell Endocrinol 2013, 368(1–2):1-16.
• [2]Gotto AM Jr, Moon JE: Management of cardiovascular risk: the importance of meeting lipid targets. Am J Cardiol 2012, 110:3A-14A.
• [3]Mannu GS, Zaman MJ, Gupta A, Rehman HU, Myint PK: Evidence of lifestyle modification in the management of hypercholesterolemia. Curr Cardiol Rev 2013, 9(1):2-14.
• [4]Johnston KL, Clifford MN, Morgan LM: Coffee acutely modifies gastrointestinal hormone secretion and glucose tolerance in humans: glycemic effects of chlorogenic acid and caffeine. Am J Clin Nutr 2003, 78(4):728-33.
• [5]Suzuki A, Yamamoto N, Jokura H, Yamamoto M, Fujii A, Tokimitsu I, Saito I: Chlorogenic acid attenuates hypertension and improves endothelial function in spontaneously hypertensive rats. J Hypertens 2006, 24(6):1065-73.
• [6]Suzuki A, Kagawa D, Ochiai R, Tokimitsu I, Saito I: Green coffee bean extract and its metabolites have a hypotensive effect in spontaneously hypertensive rats. Hypertens Res 2002, 25(1):99-107.
• [7]Yamaguchi T, Chikama A, Mori K, Watanabe T, Shioya Y, Katsuragi Y, Tokimitsu I: Hydroxyhydroquinone-free coffee: a double-blind, randomized controlled dose–response study of blood pressure. Nutr Metab Cardiovasc Dis 2008, 18(6):408-14.
• [8]Ochiai R, Jokura H, Suzuki A, Tokimitsu I, Ohishi M, Komai N, Rakugi H, Ogihara T: Green coffee bean extract improves human vasoreactivity. Hypertens Res 2004, 27(10):731-7.
• [9]Murase T, Misawa K, Minegishi Y, Aoki M, Ominami H, Suzuki Y, Shibuya Y, Hase T: Coffee polyphenols suppress diet-induced body fat accumulation by downregulating SREBP-1c and related molecules in C57BL/6J mice. Am J Physiol Endocrinol Metab 2011, 300(1):E122-33.
• [10]Murase T, Yokoi Y, Misawa K, Ominami H, Suzuki Y, Shibuya Y, Hase T: Coffee polyphenols modulate whole-body substrate oxidation and suppress postprandial hyperglycaemia, hyperinsulinaemia and hyperlipidaemia. Br J Nutr 2012, 107(12):1757-65.
• [11]Cho AS, Jeon SM, Kim MJ, Yeo J, Seo KI, Choi MS, Lee MK: Chlorogenic acid exhibits anti-obesity property and improves lipid metabolism in high-fat diet-induced-obese mice. Food Chem Toxicol 2010, 48(3):937-43.
• [12]Wan CW, Wong CN, Pin WK, Wong MH, Kwok CY, Chan RY, Yu PH, Chan SW: Chlorogenic acid exhibits cholesterol lowering and fatty liver attenuating properties by up-regulating the gene expression of ppar-α in hypercholesterolemic rats induced with a high-cholesterol diet. Phytother Res 2013, 27(4):545-551.
• [13]Rodriguez de Sotillo DVR, Hadley M: Chlorogenic acid modifies plasma and liver concentrations of: cholesterol, triacylglycerol, and minerals in (fa/fa) Zucker rats. J Nutr Biochem 2002, 13(12):717-726.
• [14]Karthikesan K, Pari L, Menon VP: Antihyperlipidemic effect of chlorogenic acid and tetrahydrocurcumin in rats subjected to diabetogenic agents. Chem Biol Interact 2010, 188(3):643-50.
• [15]Lieschke GJ, Currie PD: Animal models of human disease: zebrafish swim into view. Nat Rev Genet 2007, 8(5):353-67.
• [16]Anderson JL, Carten JD, Farber SA: Zebrafish lipid metabolism: from mediating early patterning to the metabolism of dietary fat and cholesterol. Methods Cell Biol 2011, 101:111-4.
• [17]Hölttä-Vuori M, Salo VT, Nyberg L, Brackmann C, Enejder A, Panula P, Ikonen E: Zebrafish: gaining popularity in lipid research. Biochem J 2010, 429(2):235-42.
• [18]Stoletov K, Fang L, Choi SH, Hartvigsen K, Hansen LF, Hall C, Pattison J, Juliano J, Miller ER, Almazan F, Crosier P, Witztum JL, Klemke RL, Miller YI: Vascular lipid accumulation, lipoprotein oxidation, and macrophage lipid uptake in hypercholesterolemic zebrafish. Circ Res 2009, 104(8):952-60.
• [19]Westerfield M, Streisinger G: THE ZEBRAFISH BOOK Edition 5 A guide for the laboratory use of zebrafish Danio* (Brachydanio) rerio. University of Oregon Press; 2007.
• [20]Guide for the Care and Use of Laboratory Animals Eight edition. The National Academies Press; 2010.
• [21]Folch J, Lees M, Sloane Stanley GH: A simple method for the isolation and purification of total lipids from animal tissues. J Biol Chem 1957, 226(1):497-509.
• [22]Lennernäs H, Fager G: Pharmacodynamics and pharmacokinetics of the HMG-CoA reductase inhibitors. Similarities and differences. Clin Pharmacokinet 1997, 32(5):402-425.
• [23]Grundy SM: Cholesterol-lowering drugs as cardioprotective agents. Am J Cardiol 1992, 70(21):27I-32I.
• [24]Hussain MM, Bakillah A: New approaches to target microsomal triglyceride transfer protein. Curr Opin Lipidol 2008, 19(6):572-8.
• [25]Chiang JY: Bile acids: regulation of synthesis. J Lipid Res 2009, 50(10):1955-66.
• [26]Chang BH, Liao W, Li L, Nakamuta M, Mack D, Chan L: Liver-specific inactivation of the abetalipoproteinemia gene completely abrogates very low density lipoprotein/low density lipoprotein production in a viable conditional knockout mouse. J Biol Chem 1999, 274(10):6051-5.
• [27]Li T, Owsley E, Matozel M, Hsu P, Novak CM, Chiang JY: Transgenic expression of cholesterol 7alpha-hydroxylase in the liver prevents high-fat diet-induced obesity and insulin resistance in mice. Hepatology 2010, 52(2):678-90.
• [28]Cuccioloni M, Mozzicafreddo M, Spina M, Tran CN, Falconi M, Eleuteri AM, Angeletti M: Epigallocatechin-3-gallate potently inhibits the in vitro activity of hydroxy-3-methyl-glutaryl-CoA reductase. J Lipid Res 2011, 52(5):897-907.
• [29]Hirsova P, Kolouchova G, Dolezelova E, Cermanova J, Hyspler R, Kadova Z, Micuda S: Epigallocatechin gallate enhances biliary cholesterol secretion in healthy rats and lowers plasma and liver cholesterol in ethinylestradiol-treated rats. Eur J Pharmacol 2012, 691(1–3):38-45.
• [30]Cho IJ, Ahn JY, Kim S, Choi MS, Ha TY: Resveratrol attenuates the expression of HMG-CoA reductase mRNA in hamsters. Biochem Biophys Res Commun 2008, 367(1):190-4.
• [31]Shin SK, Ha TY, McGregor RA, Choi MS: Long-term curcumin administration protects against atherosclerosis via hepatic regulation of lipoprotein cholesterol metabolism. Mol Nutr Food Res 2011, 55(12):1829-40.
• [32]Yiu WF, Kwan PL, Wong CY, Kam TS, Chiu SM, Chan SW, Chan R: Attenuation of fatty liver and prevention of hypercholesterolemia by extract of Curcuma longa through regulating the expression of CYP7A1, LDL-receptor, HO-1, and HMG-CoA reductase. J Food Sci 2011, 76(3):H80-9.
• [33]Kim HK, Jeong TS, Lee MK, Park YB, Choi MS: Lipid-lowering efficacy of hesperetin metabolites in high-cholesterol fed rats. Clin Chim Acta 2003, 327(1–2):129-37.
• [34]Fang L, Harkewicz R, Hartvigsen K, Wiesner P, Choi SH, Almazan F, Pattison J, Deer E, Sayaphupha T, Dennis EA, Witztum JL, Tsimikas S, Miller YI: Oxidized cholesteryl esters and phospholipids in zebrafish larvae fed a high cholesterol diet: macrophage binding and activation. J Biol Chem 2010, 285(42):32343-51.
• [35]Owens AP 3rd, Passam FH, Antoniak S, Marshall SM, McDaniel AL, Rudel L, Williams JC, Hubbard BK, Dutton JA, Wang J, Tobias PS, Curtiss LK, Daugherty A, Kirchhofer D, Luyendyk JP, Moriarty PM, Nagarajan S, Furie BC, Furie B, Johns DG, Temel RE, Mackman N: Monocyte tissue factor-dependent activation of coagulation in hypercholesterolemic mice and monkeys is inhibited by simvastatin. J Clin Invest 2012, 122(2):558-68.
• [36]Kita T, Kume N, Minami M, Hayashida K, Murayama T, Sano H, Moriwaki H, Kataoka H, Nishi E, Horiuchi H, Arai H, Yokode M: Role of oxidized LDL in atherosclerosis. Ann N Y Acad Sci 2001, 947:199-205.
• [37]Gordon MH, Wishart K: Effects of chlorogenic acid and bovine serum albumin on the oxidative stability of low density lipoproteins in vitro. J Agric Food Chem 2010, 58(9):5828-33.
• [38]Chang WC, Chen CH, Lee MF, Chang T, Yu YM: Chlorogenic acid attenuates adhesion molecules upregulation in IL-1beta-treated endothelial cells. Eur J Nutr 2010, 49(5):267-75.
• [39]Bøhn SK, Ward NC, Hodgson JM, Croft KD: Effects of tea and coffee on cardiovascular disease risk. Food Funct 2012, 3(6):575-91.
• [40]Di Castelnuovo A, di Giuseppe R, Iacoviello L, de Gaetano G: Consumption of cocoa, tea and coffee and risk of cardiovascular disease. Eur J Intern Med 2012, 23(1):15-25.
• [41]Hiramoto K, Li X, Makimoto M, Kato T, Kikugawa K: Identification of hydroxyhydroquinone in coffee as a generator of reactive oxygen species that break DNA single strands. Mutat Res 1998, 419(1–3):43-51.
• [42]Suzuki A, Fujii A, Jokura H, Tokimitsu I, Hase T, Saito I: Hydroxyhydroquinone interferes with the chlorogenic acid-induced restoration of endothelial function in spontaneously hypertensive rats. Am J Hypertens 2008, 21(1):23-7.